What Is the First-Line Treatment for Juvenile Xanthogranuloma?

Juvenile xanthogranuloma (JXG) is a benign histiocytic disorder that most commonly presents with self-limited cutaneous lesions. For the vast majority of patients with asymptomatic lesions, management centres on careful clinical observation rather than immediate intervention.

Clinical Approach — First-Line

A conservative, observation-based strategy is the preferred first-line option for most asymptomatic cases, reflecting the natural history of this condition. The full protocol specifies the criteria that guide this approach and the circumstances under which further steps may be considered.

Full eligibility criteria, decision points, and structured regimen available below ↓

Instant Access to Structured Evidence-Based Regimens

References

A watch and wait approach is the first-line option for the vast majority of asymptomatic lesions.

JXG does not typically require treatment as it generally follows a benign course, with lesions resolving spontaneously within approximately 3 to 6 years.

DOI: 10.1016/j.adengl.2020.10.007

View source ↗